Recursion Pharmaceuticals, Inc. (RXRX) SEC Filings — 2024

Filings

• Recursion Pharmaceuticals Files 8-K — 8-K · Dec 17, 2024
• Recursion Pharma Appoints New CMO, CBO; Gibson Departs — 8-K · Dec 3, 2024
• Recursion Pharma Files 8-K/A Amendment — 8-K/A · Nov 27, 2024
• Recursion Pharma Amends Equity Filing — 8-K/A · Nov 26, 2024
• Recursion Pharma Completes Cyclica Acquisition, Sees Exec Changes — 8-K · Nov 20, 2024
• Recursion Pharmaceuticals Files 8-K — 8-K · Nov 13, 2024
• Recursion Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Recursion Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Recursion Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 8, 2024
• Recursion Pharmaceuticals Enters Material Definitive Agreement — 8-K · Nov 6, 2024
• Recursion Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 6, 2024
• Recursion Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
• Recursion Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
• Recursion Pharma Files Proxy Materials — DEFA14A · Oct 30, 2024
• Recursion Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Oct 22, 2024
• Recursion Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Oct 18, 2024
• Recursion Pharma Acquires Subsidiary for $10M — 8-K · Oct 2, 2024
• Recursion Pharma Files Proxy Solicitation Material — DEFA14A · Sep 19, 2024
• Recursion Pharma Files Proxy Statement, No Fee — DEFA14A · Sep 4, 2024
• Recursion Pharmaceuticals Files 8-K — 8-K · Sep 3, 2024
• Recursion Pharmaceuticals Files 8-K — 8-K · Aug 28, 2024
• Recursion Pharma Files Proxy Statement — DEFA14A · Aug 9, 2024
• Recursion Pharma Appoints New Chief Medical Officer — 8-K · Aug 8, 2024
• Recursion Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
• Recursion Pharmaceuticals Files 8-K — 8-K · Aug 6, 2024
• Recursion Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Jul 8, 2024
• Recursion Pharma Partners with NVIDIA for AI Drug Discovery — 8-K · Jun 27, 2024
• Recursion Pharma Partners with NVIDIA for AI Drug Discovery — 8-K · Jun 24, 2024
• Recursion Pharmaceuticals Reports on Shareholder Vote Outcomes — 8-K · Jun 7, 2024
• Recursion Pharma CFO Departs, Auditor Resigns — 8-K · May 24, 2024
• Recursion Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
• Recursion Pharmaceuticals, Inc. Files Definitive Proxy Statement — DEF 14A · Apr 23, 2024
• Recursion Pharmaceuticals Appoints New Chief Legal Officer — 8-K · Apr 16, 2024
• Recursion Pharmaceuticals, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 29, 2024
• Recursion Pharma Files 8-K on Financial Results and Disclosures — 8-K · Feb 27, 2024
• Recursion Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• ARK Investment Management Updates Recursion Pharma Stake — SC 13G/A · Feb 12, 2024
• FMR LLC Discloses 5.23% Passive Stake in Recursion Pharma — SC 13G · Feb 9, 2024
• Recursion Pharma Files Routine 8-K; No Major Changes Reported — 8-K · Feb 7, 2024
• Recursion Pharma Amends Bylaws/Articles; Nasdaq Listing Confirmed — 8-K · Jan 31, 2024
• ARK Invest Discloses 20.6M Share Stake in Recursion Pharma — SC 13G · Jan 29, 2024
• BlackRock Amends Recursion Pharma Stake, Signals Continued Confidence — SC 13G/A · Jan 29, 2024
• Baillie Gifford Amends Recursion Pharma Stake (SC 13G/A) — SC 13G/A · Jan 26, 2024
• State Street Corp. Discloses Initial Stake in Recursion Pharma — SC 13G · Jan 24, 2024
• Recursion Pharma Files 8-K for Reg FD Disclosure — 8-K · Jan 8, 2024